Crescent Biopharma, Inc. (CBIO) Revenue 2016–2025
Crescent Biopharma, Inc. (CBIO) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$10.8MFY2025 · since FY2016: $18,500 → $10.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $10.8M | — |
| FY2023 | $10,000 | -86.7% |
| FY2022 | $75,000 | -93.5% |
| FY2021 | $1.2M | -88.6% |
| FY2020 | $10.2M | — |
| FY2016 | $18,500 | — |
Source: SEC XBRL filings · For reference only · Not investment advice